Volume 50, Issue 6 pp. 1135-1137
Research Article

Wilms tumour in Sudan

Dafalla O. Abuidris MD

Corresponding Author

Dafalla O. Abuidris MD

Department of Radiation Oncology, Institute of Nuclear Medicine, Molecular Biology and Oncology, University of Gezira, Wad Madani, Sudan

Assistant Professor, Department of Radiation Oncology, Institute of Nuclear Medicine and Oncology, University of Gezira, PO Box 20, Wad Madani, Sudan.===Search for more papers by this author
Mohammed E. Elimam MD

Mohammed E. Elimam MD

Department of Surgery, University of Gezira, Wad Madani, Sudan

Search for more papers by this author
Faisal M. Nugud MD

Faisal M. Nugud MD

Department of Paediatric Surgery, University of Gezira, Wad Madani, Sudan

Search for more papers by this author
Elgaili M. Elgaili MD

Elgaili M. Elgaili MD

Faculty of Medicine, Department of Pathology, University of Gezira, Wad Madani, Sudan

Search for more papers by this author
Mohamed E. Ahmed MD

Mohamed E. Ahmed MD

Faculty of Medicine, Department of Paediatrics, University of Gezira, Wad Madani, Sudan

Search for more papers by this author
Ramandeep S. Arora DCH, MRCPCH

Ramandeep S. Arora DCH, MRCPCH

Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, UK

Search for more papers by this author
First published: 02 April 2008
Citations: 62

All authors have no conflict of interest to declare.

Abstract

Background

Wilms tumour is one of the commonest childhood solid tumours which has an excellent outlook in the developed world with 5-year overall survival exceeding 90%. There is little information from Sudan regarding Wilms tumour.

Procedure

Records of patients with Wilms tumour diagnosed and treated at Institute of Nuclear Medicine, Molecular Biology and Oncology (INMO) in the University of Gezira from May 1999 to June 2007 were reviewed.

Results

Thirty-seven children presented at a mean age of 4.1 years (range 2 months–13 years). The male to female ratio was 0.9–1. Abdominal swelling or mass was the commonest symptom. There was 1 child with Stage I (2.7%), 7 with stage II (18.9%), 25 with Stage III (67.6%) and 4 with Stage IV (10.8%). Following diagnosis 27% of children did not receive further treatment (5.4% died prior to treatment, 5.4% were not able to finance treatment and for the rest 16.2% no cause was identified). More than half of the children did not have a nephrectomy and only 4 (11%) completed treatment.

Conclusions

The poor outlook is related to several factors. Delayed presentation, poor awareness of treatment options, lack of finances, no provision of food, lodging and transport, absence of paediatric trained staff are the obstacles to better outcomes. Empowering parents with information, giving chemotherapy prior to nephrectomy, training staff and establishing links with a tertiary cancer centre in the developed world are some of the options to improve survival. Pediatr Blood Cancer 2008;50:1135–1137. © 2008 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.